What is CareDx's stock-based comp?

CareDx (CDNA) reported stock-based comp of $9.8M in Q1 2026.

How has CareDx's stock-based comp changed year-over-year?

CareDx's stock-based comp increased by 9.8% year-over-year, from $8.93M to $9.8M.

What is the long-term trend for CareDx's stock-based comp?

Over 4 years (2021 to 2025), CareDx's stock-based comp has grown at a -0.9% compound annual growth rate (CAGR), from $36.08M to $34.86M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

CareDx CDNA Stock-Based Comp

Stock-Based Comp at other companies

Thermo Fisher ScientificTMO

$83M+10.7%

Natera, Inc.NTRA

$95.11M+22.2%

NeoGenomicsNEO

$9.64M-10.4%

Personalis, Inc.PSNL

$2.55M+15.1%

GeneDx HoldingsWGS

$9M+126%

TransMedics Group, Inc.TMDX

$9.95M+11.1%

Segments

By segment

See full

Reportable Segment$9.77M+9.4%

Other financials

Income statement

See full

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

See full

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

See full

Market cap$1.4B+32.2%

Enterprise value$1.35B+34.6%

P/S3.4×+0.3×

Profitability

See full

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

See full

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CareDx's stock-based comp?: CareDx (CDNA) reported stock-based comp of $9.8M in Q1 2026.
How has CareDx's stock-based comp changed year-over-year?: CareDx's stock-based comp increased by 9.8% year-over-year, from $8.93M to $9.8M.
What is the long-term trend for CareDx's stock-based comp?: Over 4 years (2021 to 2025), CareDx's stock-based comp has grown at a -0.9% compound annual growth rate (CAGR), from $36.08M to $34.86M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.